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ABSTRACT
Tobacco smoking is associated with cardiovascular, respiratory, cancer-related illnesses, and
deaths. Tobacco toxin clogs blood arteries, leading to increased risks of cardiovascular diseases
or death. Smoking cessation programs have been implemented to aid patients with abstaining
from tobacco usage, particularly those with heart-related diseases. The challenges experienced in
implementing smoking cessation interventions include a lack of follow-ups, support, and
education regarding the risks associated with smoking tobacco. The aim of this project was to
examine the effectiveness of the smoking cessation intervention and programs implemented in
patients diagnosed with heart diseases. An integrative study review was applied to assess
interventions used in diverse settings to aid in tobacco cessation. The findings included that
behavioral, pharmacological, telephone, and individual counseling smoking cessation
interventions were applied to aid the patients diagnosed with heart diseases to quit smoking. The
smoking cessation interventions implemented were effective among patients diagnosed with
heart diseases, and short-term and long-term follow-ups were essential for evaluating patients'
progress.
Keywords: Tobacco use, heart diseases, smoking cessation interventions, behavioral,
pharmacological, telephone, and individual counseling interventions.
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SECTION ONE: INTRODUCTION
Background
Smoking is one of the leading causes of heart disease in the United States (Centers for
Disease Control and Prevention [CDC], 2020). Smoking tobacco causes lung diseases,
cardiovascular diseases (CVDs), and various cancers (Choi et al., 2019). According to the CDC
(2020), one in every four U.S. deaths is due to CVD. In addition, approximately 800,000 U.S.
people die of CVDs annually. Exposure to secondhand smoke also contributes to heart diseases.
The World Health Organization (WHO, 2020) evidence indicates that smoking causes 20% of
heart-related diseases and complications. People with a history of tobacco smoking have a higher
prevalence of heart failure and CVD-related complications than nonsmokers (Lee & Son, 2019).
Smoking cessation is one of the primary strategies applied to reduce tobacco use among patients
with histories of heart disease (Blane et al., 2017). Reducing tobacco use can minimize smoking
mortality and morbidity.
Problem Statement
Tobacco smoking accounts for more than 6 million annual deaths worldwide and causes
substantial morbidities related to CVD (Roy et al., 2017). In the United States, cigarette smoking
causes more than 480,000 deaths annually, including over 41,000 deaths linked to secondhand
smoke exposure (CDC, 2021). Researchers have associated smoking with blood vessel damage
that increases cardiac events' risk (Li et al., 2017). Gonzales et al. (2020) established that patients
who received smoking cessation interventions were more likely to abstain from tobacco use than
control subjects. Currently, those in the clinical setting provide standard education to promote
tobacco cessation among patients with heart diseases with smoking histories. However, increased
tobacco dependence continues among heart disease patients. The gap in practice may be
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addressed by conducting an integrative review to identify the effectiveness of smoking cessation
intervention programs in heart disease patient populations toward reducing tobacco use.
The challenge faced in the primary care setting was that smoking cessation was regarded
as the most effective action-based approach for heart disease patients who smoked; however,
more than 50% of cardiac patients continued using tobacco after admission (de Hoog et al.,
2016). Determining the self-efficacy of the intention to quit is essential to establish how effective
smoking cessation is for heart disease patients. The smoking cessation intervention approach is
integral for influencing cardiovascular patients' intentions to quit tobacco use and self-efficacy
(Busch et al., 2017; de Hoog et al., 2016). Additionally, smoking increases the risk of
cardiovascular events and sudden cardiac death (Reid et al., 2018). The utilization of smoking
cessation programs can reduce cardiovascular risks and related complications and comorbidities.
Reid et al. (2018) recommended implementing smoking cessation interventions in hospital
settings to improve patients' outcomes. Quitting smoking is a priority for patients with acute
coronary syndromes, and tobacco use cessation can reduce cardiovascular mortality and
morbidity while improving the quality of life.
Purpose of the Project
The purpose of conducting the integrative review was to assess and appraise current
evidence for the effectiveness of smoking cessation intervention programs in cardiovascular
patient populations in reducing tobacco use. Using the literature review matrix, previous research
papers were synthesized and assessed on smoking cessation programs for patient with a history
of heart disease and smoking.

SMOKING CESSATION IN HEART DISEASE PATIENTS

15

Purpose and Review Question
For this integrative review, the focus of interest entailed determining the effectiveness of
smoking cessation intervention programs in CVD patient populations toward reducing tobacco
use. Factors impacting smoking cessation were examined, and effective interventions were
discussed. The review question was the following: What is the effectiveness of smoking
cessation intervention programs in cardiovascular patient populations in reducing tobacco use?
Literature Review
Smoking is a significant issue, and various studies have been published on multiple
cessation programs. The primary focus of the literature review entailed evaluating existing
studies on smoking cessation programs and the effects on tobacco use. Section Two of the
literature review covers the search strategy applied, critical appraisal and synthesis, the
conceptual framework, and a summary.
Search Strategy
A comprehensive literature search was conducted using scholarly and peer-reviewed
nursing journal databases. The databases included MEDLINE, PsycINFO, Google Scholar,
Cochrane Database of Systematic Reviews, and PubMed. The search terms included smoking
cessation, heart diseases, history of smoking and heart diseases, education programs for
smoking, and tobacco use. The Boolean operator AND was included when conducting the search
to filter the findings. The initial search from PubMed generated 32 articles, including 13 from
Google Scholar, 11 from Medline, seven from Cochrane, and five from PsycINFO. Fifteen
articles were generated from databases that aligned with the inclusion and exclusion criteria.
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Inclusion and Exclusion Criteria
The inclusion criteria comprised scholarly and peer-reviewed articles (a) published
between 2016 and 2020, (b) written in the English language, (d) targeting smoking cessation
interventions and heart diseases, and (e) written in full text. All articles were excluded from the
list if published before 2016, not written in English, not peer-reviewed studies, and not in full
text. Also, all publications lacking original data, including editorials and opinion pieces, were
excluded. Fifteen articles met the inclusion and exclusion criteria; thus, these were included in
the project proposal's preliminary literature review.
Synthesis
Nine studies were systematic reviews (Barth et al., 2016; Chehab & Dakik, 2018; Gupta
et al., 2019; Hyndman et al., 2019; Lee & Son, 2019; Prochaska & Benowitz, 2016; Rice et al.,
2017; Semwal et al., 2019; Suissa et al., 2017). The articles also contained three observational
cross-sectional studies (Blane et al., 2017; Mullen et al., 2017; Snaterse et al., 2018), one
longitudinal study (de Hoog et al., 2016), one cohort study (Goettler et al., 2020), and one mixed
approach (Patterson et al., 2017). Table 2 shows the articles' appraisals in an evaluation matrix,
indicating each article’s strengths, weaknesses, and levels of evidence (see Appendix A).
Cigarette smoking is a causative factor for coronary artery disease and contributes to
thrombus formation, endothelial dysfunction, and atherosclerosis (Barth et al., 2016; de Hoog et
al., 2016). According to Mullen et al. (2017), integrating hospital-initiated smoking cessation
intervention played a significant role in reducing patients' mortality and health issues. The
patients supported by the intervention experienced significantly lower rates of all-cause
readmissions, all-cause emergency department (ED) visits, and smoking-related
rehospitalizations. Smoking cessation is recommended to reduce cardiovascular-related
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complications and mortality risks (Barth et al., 2016; Mullen et al., 2017; Prochaska & Benowitz,
2016). A meta-analysis has indicated that individual and telephone counseling, Varenicline, and
bupropion are efficacious for CVD patients' smoking cessation (Suissa et al., 2017). Chehab and
Dakik (2018) contended that pharmacological interventions were effective in smoking cessation;
however, the best findings for smoking cessation entailed using combinations of behavioral and
pharmacological interventions.
A consensus shows that education-based programs can enhance smoking cessation
among patients with heart diseases (Hyndman et al., 2019; Semwal et al., 2019). Education can
improve healthcare providers' skills and knowledge to impact smoking cessation programs
positively. De Hoog et al. (2016) found that action-based coping plans increased heart disease
patients' intentions to quit tobacco use after engaging in a smoking cessation program. According
to Blane et al. (2017), patients with tobacco use problems required smoking cessation support to
change their habits. Goettler et al. (2020) established that patients who attended a cardiac
rehabilitation program following a CVD event reported a high likelihood of smoking cessation.
Although smoking cessation interventions' efficacies were well established, the effectiveness in
patients with heart diseases remained unclear (Suissa et al., 2017). The identified literature gap
was addressed through this integrative review by evaluating the effectiveness of smoking
cessation intervention programs in heart disease patients in reducing tobacco use.
The relationship between smoking and the incidence of heart failure is direct, increasing
the risk of death. Lee and Son (2019) found that smokers aged 18 years had a higher risk of heart
failure than nonsmokers. Similarly, Gupta et al. (2019) found that smokeless tobacco increased
the risk of CHD; as a result, the reserachers recommended smoking cessation interventions.
Additionally, the study findings showed that cessation efforts were required for smokeless
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tobacco products because of a link to fatal cardiac events. Rice et al. (2017) established that
nursing‐delivered smoking cessation interventions were effective in increasing patient success in
quitting tobacco use.
Researchers agreed that smoking had adverse effects on persons with a history of tobacco
use; thus, such researchers recommended smoking cessation (Gupta et al., 2019; Lee & Son,
2019; Rice et al., 2017). Leaders of smoking cessation programs have the role of increasing
knowledge and fostering positive attitudes among tobacco users (Patterson et al., 2017). A study
conducted in Europe using the EUROASPIRE IV survey showed that smoking cessation
encouraged more than 50% of the participants to quit tobacco use (Snaterse et al., 2018). The
findings further indicated that successful quitters received counseling while under a cardiac
rehabilitation program, which allowed them to make healthy lifestyle changes (Patterson et al.,
2017; Snaterse et al., 2018).
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SECTION TWO: REVIEW OF THE LITERATURE
Conceptual Framework/Model
The current study used suggestions by Whittemore and Knafl (2005) as the conceptual
framework for this integrative review. This framework comprised five distinct phases: (a)
problem identification, (b) data collection or literature search, (c) evaluation of data, (d) data
analysis, and (e) interpretation and presentation of results. Phase 1 entailed identifying the
problem under study, and this integrative review targeted the effectiveness of smoking cessation
interventions in persons with heart disease. Phase 2 comprised a literature search using various
databases, including MEDLINE, PsycINFO, Cochrane Database of Systematic Reviews, and
PubMed (Whittemore & Knafl, 2005). Phase 3 was the data evaluation and entailed extracting
methodological characteristics of primary studies included in the meta-analysis and systematic
reviews. Evaluating the quality of primary sources in the integrative review was included to
determine the selected articles' quality. Data analysis entailed extracting findings from primary
sources.
Phase 4 entailed data display by converting the extracted data into subgroups. The next
phase of data analysis was the comparison, which entailed an interactive process of evaluating
the displays of primary sources (Whittemore & Knafl, 2005). The rationale was to identify
themes, patterns, and relationships in the collected data. The final process of data analysis
entailed conclusion drawing and verification with abstraction and subsuming of patterns, themes,
and relations. The fifth phase of the integrative reviews was the presentation of the findings in a
table and diagrammatic form. Figure 1 shows the project's conceptual framework (see Appendix
B).
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Theoretical Framework
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model (see Figure 1)
was applied in the integrative review and provided guidance for the search and translation of
evidence (see Dang & Dearholt, 2017). The phases of the three-step model included practice
question, evidence, and translation. The first step entailed the formulation question to be resolved
using EBP and current literature findings. The second step included finding the evidence to be
reviewed and synthesized from reliable electronic and online databases (Dang & Dearholt,
2017). The major elements of the practice question were considered during the search process.
The doctoral student focused on Google Scholar, Cochrane Database of Systematic Reviews, and
PubMed databases when searching for peer-reviewed and scholarly evidence. The third phase
was the translation of evidence to establish the main findings and gaps in the literature. The
model helped establish the evidence level and quality of the findings when answering the
integrative review question.
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Figure 1
Johns Hopkins Nursing Evidence-Based Practice Model

Note. Adapted from Johns Hopkins nursing evidence-based practice: Model and guidelines (p.
172), by D. Dang and S. Dearholt, 2017, Sigma Theta Tau International. Copyright 2017 by the
Sigma Theta Tau International.
Summary
Tobacco use is a leading cause of heart disease and CVD-related complications. Patients
with CVD and histories of smoking have high risks of cardiac arrest and increased premature
death prevalence. The findings from the reviewed literature indicated that using education-based
programs improved smoking cessation. Additionally, tobacco dependence education was
important for preparing nurses and supporting patients with smoking cessation.
The JNEBP model was applied in the integrative review to offer guidance for the search
and translation of evidence. The three phases of the JHNEBP model included practice question,
evidence, and translation. Whittemore and Knafl (2005) provided the conceptual framework used
in the integrative review. The purpose of conducting the integrative review was to assess and
appraise current evidence for the effectiveness of smoking cessation intervention programs in
cardiovascular patient populations toward reducing tobacco use.
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SECTION THREE: METHODOLOGY
Design
The purpose of conducting the project was to identify the effective interventions for
smoking cessation with positive outcomes on CVD patients. The project was an integrative
review conducted to assess and appraise current evidence for the effectiveness of smoking
cessation programs in cardiovascular patient populations in reducing tobacco use. An additional
outcome of interest was the effectiveness of the intervention on improving health outcomes in
patients with cardiovascular disease. In the review, the DNP student synthesized and analyzed
the relevant studies published on smoking cessation programs on heart patients with histories of
smoking, summarizing previous research.
The review involved qualitative and quantitative studies on smoking cessation programs
for cardiovascular patients. In this section, the methods and procedures used by the DNP student
to conduct the integrative review are presented. The methods used to search, screen, select, and
sort the literature are presented. Additionally, the strategies for appraisal and reporting the
review results are presented.
Measurable Outcomes
Both dependent and independent variables guided the integrative review. Smoking
cessation was the dependent variable. The independent variables included outcome expectation,
perceived behavioral change, and the intention to quit tobacco use after smoking cessation
interventions (Atmojo et al., 2018).
Setting
The project was based on an integrative literature review; therefore, no practicum setting
was applicable. The rationale for conducting the integrative review was to establish the

SMOKING CESSATION IN HEART DISEASE PATIENTS

23

effectiveness of smoking cessation intervention programs in reducing tobacco use among
patients diagnosed with heart diseases. The current challenge faced in the primary care setting is
that more than 50% of cardiac patients use tobacco after admission regardless of the
effectiveness of smoking cessation (de Hoog et al., 2016). The findings of the integrative review
will significantly contribute to the nursing practice. Nurses can use the results to improve their
knowledge about how smoking cessation interventions may influence heart disease populations.
Population
The participants of this DNP project included three nurse practitioners part of the expert
panel for the DNP project. The practitioners roles were to provide guidance throughout the DNP
project and help with reviewing the final manuscript.
Ethical Considerations
Ethical requirements were necessary when performing an integrative literature review
project. The DNP student obtained ethical approval from relevant authorities. Approval was
obtained from the DNP Project Committee and Liberty University's Institutional Review Board
(IRB) through the standard requirement procedures. The IRB approval did not permit the
collection and analysis of data from the integrative literature review. In this integrative literature
review project, a survey or interview for individuals was not used. There was no collection of
any form of data from human subjects. All the reviewed studies were referenced in the proposal
as part of ensuring ethical considerations.
Intervention
This section provides a concise step-by-step description of the DNP project process from
beginning to end. Seven main steps were followed in the process of writing and completing the
DNP project. These steps included identifying the area of interest; developing a written proposal;
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obtaining IRB approval; collecting data; writing the final project; and presenting, submitting, and
disseminating the findings.
Step 1: Identifying the Area of Interest
The DNP student identified the area of interest and then submitted the proposal to the
DNP proposal committee for approval. After approval from the DNP proposal committee, a DNP
project chair was assigned. The identified topic was "Effectiveness of the Smoking Cessation in
Heart Disease Patients: An Integrative Review."
Step 2: Developing the Written Proposal
The purpose of writing the proposal was to demonstrate the ability to conduct an
evidence-based project by following a scientific process. The DNP student submitted the
completed written proposal to the DNP chair for review and approval. The proposal was
reviewed against the scholarly project proposal rubric, feedback was provided, and
recommended changes were completed. The sections completed in the project proposal included
the introduction, literature review, and project methodology.
Step 3: Obtaining IRB Approval
The DNP student obtained ethical approval from Liberty University's IRB. The IRB
approval only permitted the collection and analysis of the integrative literature review data
because no human subjects were utilized.
Step 4: Executing the Project and Collecting Data
The data collection entailed an integrative review of articles published between 2016 and
2020 that supported smoking cessation interventions. The databases searched included PubMed,
Cumulative Index to Nursing and Allied Health Literature, Agency for Health Care Research and
Quality Patient Safety Network, and the Public Library of Science. The DNP student used the
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PRISMA as the reporting guideline for the review. The articles were screened, appraised, sorted,
and presented in a literature review matrix.
Step 5: Writing the Final Project
The final report of the DNP project was a scholarly paper that followed a specific format
provided by Liberty University. In addition to Section One, Two, Three, and Four included in the
original proposal, the final report included the title page, abstract, table of contents, Section Five,
references, and appendices.
Step 6: Orally Presenting and Submitting the Completed Project Copies
During this phase, the DNP student developed and presented a 30-minute presentation of
the project using PowerPoint. Also, the final copies were submitted to the scholarly project’s
chair.
Step 7: Disseminating the DNP Project
Dissemination of the DNP project will include center presentations at cardiovascular
nursing symposia and community health promotion events. The project will be distributed in
institutions, such as the Veteran Administration Center for Information Dissemination and
Educational Resources.
Data Collection
In conducting the integrated review, the DNP student searched the Internet to find articles
published between 2016 and 2020 that showed support for smoking cessation interventions. The
search was conducted on specific databases, in addition to backward reference searching. Some
referenced materials in the identified studies were hand-searched based on meeting the inclusion
criteria and being unlisted in the databases considered. The databases searched included
PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Agency for Health
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Care Research and Quality Patient Safety Network, and the Public Library of Science. These
databases were appropriate because each was accessible to the DNP student and contained peerreviewed medical, nursing, and allied health literature. The literature in these databases included
articles from scholarly journals published by multiple publishers, as well as conference
proceedings reports.
The literature search was conducted using both natural language and keyword search
strategies. The search, using keywords, was conducted in the three databases followed by natural
language use and then a backward reference search. Using natural language captures the term
despite whether specific keywords are used in the search (Toronto & Remington, 2020).
Therefore, conducting a literature search using natural language yields more results than when
specific keywords are used, although the latter is more structured. Using both strategies
optimized the search results by ensuring that as much as possible was found and that the
literature was presented in a systematic manner.
The search outcomes for each keyword and database were saved and documented to aid
in the study selection. The search was limited to studies published between 2016 and 2020
because of the validity of the intervention. The articles were also limited to primary studies
conducted either qualitatively or quantitatively. All the saved database search results were
further screened to determine which studies met the integrative review eligibility criteria. The
screening entailed reviewing the study titles to eliminate duplicates and remove those that did not
represent smoking cessation interventions. The next screening stage was conducted by reviewing
the abstracts of the studies to clarify further the relevance to the current study topic. At the
elimination stage, all the excluded studies were documented, as well as the potentially relevant
ones retained. Further screening was continued later for the full articles. Additional search
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methods, such as hand searching and backward reference searching, were applied after the initial
screenings of the article topics and abstracts. The search was conducted after both natural
language and keyword-searched literature had been screened to facilitate the inclusion of unique
materials in the integrative review.
In the event studies were referenced in the articles found using keyword searches not
included in the four databases searched, a natural language search was conducted. In this stage,
backward reference searches were conducted, where the studies cited that contained evidence on
smoking cessation interventions were sought. The studies were reviewed to establish if available
in full text. The studies were then documented based on inclusion in the integrative review. The
search was conducted using the Google Scholar search engine.
Tools
Reporting guidelines refer to the checklist of items that should be included in the
integrative review report (Toronto & Remington, 2020). According to the National Library of
Medicine (2015), reporting guidelines specify the minimum set of items reported to provide a
clear and transparent account of the research process and study findings. The DNP student used
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) as the
reporting guideline for the review. The PRISMA guideline is preferred because of its ability to
minimize bias in the final reporting. The PRISMA focuses on how the review is reported rather
than on how the studies are appraised, ensuring that only the minimum description of
characteristics is used while increasing the quality and transparency of the review (Moher et al.,
2015).
The PRISMA reporting guidelines consist of a flow diagram and checklist of items
essential to clear, transparent reporting (Moher et al., 2015). The flow diagram presents the
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processes of study article identification, screening, and selection. Instead of using the 27 original
checklist items in the PRISMA guideline, the PRISMA guideline authors used the 22 items
recommended in the PRISMA extension for scoping reviews (PRISMA-ScR). The 22-item
checklist addressed the final review report, including the outcomes of the appraisal. The
PRISMA-ScR checklist was developed by a 24-member expert panel and two search leads that
followed published guidance from the Enhancing the Quality and Transparency of Health
Research Network. The checklist consists of 20 essential and two optional reporting items. The
checklist is also more appropriate for an integrative review (Tricco et al., 2018).
The appraisal of each study article in the review was reported. The report included a
description of how each article was appraised, the criteria used to determine quality, and the
appraisal results. The report also included documentation of any article excluded based on the
quality appraisal. The appraisal notation was entered into a matrix to support the credibility of
the analysis and review findings. The matrix was constructed to represent the outcome of the
appraisal and contained columns for the study title, design and method, sampling technique and
sample size used, methods for data collection, results, and relevance to the review. Additionally,
a discussion of the appraisal outcome was presented.
The type of quality appraisal tool affects the quality of an integrative review and the
conclusions. The DNP student used critical appraisal to evaluate the evidence using structured
questions and a checklist. The rapid critical appraisal checklists by Melnyk and Fineout-Overholt
(2015) were used to appraise the studies in the review. Critical appraisal checklists are
considered appropriate tools for novice and expert consumers of evidence (Melnyk & FineoutOverholt, 2015). Melnyk and Fineout-Overholt (2015) proposed a general appraisal of all the
studies using the PICOT question; a general overview of the study regarding the purpose, design,
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and sampling; and then the rapid critical appraisal checklists. The checklists are recommended
for descriptive studies, evidence-based practice implementation or quality improvement projects,
cohort studies, randomized controlled trials, systematic reviews of clinical interventions or
treatments, qualitative evidence, and evidence-based guidelines (Melnyk & Fineout-Overholt,
2015).
The rapid appraisal checklists were the most appropriate for this review because of being
developed for evidence-based practical use (Melnyk & Fineout-Overholt, 2015). Therefore,
using the checklists to appraise the quality of evidence was more appropriate for identifying the
intervention best suited for evidence-based practical application, which was the goal of the
review. The checklists were used to appraise both the qualitative and quantitative studies. The
goal was to determine the type of smoking cessation program selected as the most effective for
cardiovascular patients.
Screening
The identified articles were screened for relevance by considering the titles and abstracts.
At this stage, the eligibility criteria were not considered; instead, the DNP student sought to
locate irrelevant studies by skimming through titles and abstracts (see Toronto & Remington,
2020). In the integrative review, the DNP student searched through titles to identify and exempt
studies that did not include at least one of the phrases in the search keywords. The articles that
remained after the first screening were then reviewed based on the abstracts, and those that did
not include cardiovascular disease patients were exempted from the review. The second
screening significantly reduced the number of articles in the study when the hand and backward
reference searching commenced.
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Selection
After the abstracts were reviewed and only the relevant studies remained in the review,
the DNP student selected the studies that met the eligibility criteria for full text. During the initial
search, some eligibility criteria, such as year and language of publishing, were considered. In this
stage, the studies remaining in the review already met the criteria for relevance, were less than
five years old, and were published in the English language. Further screening was conducted to
only select the articles available in full text. The selected articles were documented and saved in
a different file with links to the full text for further reading and screening.
Sorting
The final stage of the screening involved sorting the articles based on the evidence. In
this stage, the DNP student read through all the remaining articles and classified each according
to the type of evidence, such as primary, secondary, qualitative, quantitative, or journal articles
(among others). The sorting facilitated further identification of duplicate evidence, where the
same report might be published in different formats. All the articles were sorted into the different
categories of evidence relevant to the review. Any duplicates were eliminated; however, all the
elimination was usually completed when the DNP student got to the sorting stage (see Toronto &
Remington, 2020). Therefore, the sorting stage presented the classification of the evidence.
The screening and selection outcomes included removing most identified literature. The
processes were documented visually using the PRISMA flowchart, which highlighted the
number of studies found and elimination processes during the different stages until the final
number of reviewed studies was reached (Moher et al., 2015). The Covalence software was
helpful in developing the PRISMA flowchart, although the DNP student only used the format to
develop the chart relevant for the review.
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SECTION FOUR: RESULTS
Data Analysis
The entire search process and outcomes were documented. Documenting the search
report facilitates reproducibility by other researchers (Toronto & Remington, 2020). The initial
stages of the review included screening the search outcomes to establish if the identified articles
met the eligibility criteria for age and relevance to the topic, were not duplicates, and were
available in full text. The Covidence software was used to screen the articles from the three
databases and manage the search results. The software offered a free first trial and was preferred
because it enabled adding citations from multiple sources, extracting data extraction, and
creating a PRISMA flowchart (see Hansen, 2021).
The article citations were listed in a table column, with the adjacent columns containing
information on whether the article met the criteria for relevance, uniqueness, and availability in
full text. All the search results underwent screening, selecting, and sorting to identify the articles
used in the review. Toronto and Remington (2020) recommended piloting each of the three steps,
including screening, sorting, and selecting, before completion. The DNP student piloted each
step and documented the entire process of finding data for the review. The DNP student also
developed a PRISMA flowchart to display the flow of the articles through the screening and
selection processes.
Findings
Tobacco and cigarette smoking cause respiratory, cardiovascular, and various cancer
diseases that lead to death (CDC, 2020). Over 800,000 U.S. CVD deaths are reported every year,
with 20% of the mortality being tobacco or cigarette smokers (Food and Drug Administration
[FDA], 2018). According to an article published by the U.S. Department of Health and Human
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Services (USDHHS), smoking cessation programs have been effective, as there are more
nonsmokers than smokers. Moreover, 67% of smokers have expressed the desire to quit
smoking. Although 50% of smokers try to quit each year, only 10% manage to quit smoking
(USDHHS, 2020).
The project was designed to assess the effectiveness of smoking cessation in heart disease
patients through an integrative review of articles and studies related to the topic. The objective of
the study was to evaluate the current evidence for the effectiveness of smoking cessation
intervention programs in CVD patient populations in reducing smoking. The clinical question
used to guide the project was the following: What is the effectiveness of smoking cessation
intervention programs in the CVD patient population in reducing tobacco use? This section
presents the results of the integrative review of the articles selected.
Screening
A total of 15 articles were selected from PubMed, COCHRANE, PLOS One, Google
Scholar, and PsycINFO. Fifteen articles were imported in the Covidence software, one was
eliminated, and 14 were eligible for inclusion in the study, with the results displayed in a
PRISMA shown in Figure 2.
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Figure 2
PRISMA Flowchart of the Screening Stage of the Articles Selected

Note. Adapted from “The integrative review: Updated methodology,” by R. Whittemore and K.
Knafl, 2005, Journal of Advanced Nursing, 52(5), p. 546 (https://doi.org/10.1111/j.13652648.2005.03621.x). Copyright 2005 by Wiley & Sons.
Inclusion
Fourteen articles met the criteria for relevance, full-text availability, and uniqueness, as
indicated in Table 2.
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Table 2
Thematic Analysis Table
Article citation

Type of study

Purpose of the study

Results

Barth, J., Jacob, T., Daha, I., & Critchley, J. A. (2016).
Psychosocial interventions for smoking cessation in
patients with coronary heart disease. Cochrane
Database of Systematic Reviews, 7(CD006886), 1-105.
https://doi.org/10.1002/14651858.CD006886.pub2.

Systematic review

Evaluate the effectiveness of the
psychosocial interventions for
smoking cessation in patients
diagnosed with coronary heart
disease in the short and long term
and moderators of treatment effects
used for stratification.

There was a positive effect of
interventions on abstinence after 6
to 12 months (risk ratio (RR)
1.22, 95% confidence interval
(CI) 1.13 to 1.32, I² 54%;
abstinence rate treatment group =
46%, abstinence rate control
group 37.4.

Blane, D. N., Mackay, D., Guthrie, B., & Mercer, S. W.
(2017). Smoking cessation interventions for patients
with coronary heart disease and comorbidities: An
observational cross-sectional study in primary care. The
British Journal of General Practice, 67(655), e118–
e129. https://doi.org/10.3399/bjgp16X688405

Cross-sectional study

The study's objective was to
determine the correlation between
diverse patterns of comorbidity and
smoking rates and smoking
cessation interventions in a primary
care setting.

The most deprived smoking
cessation interventional advice
quartile had a higher odds ratio of
current smokers than those
receiving the intervention OR
[2.76; 95% CI [2.49- 3.05].

Chehab, O. M., & Dakik, H. A. (2018). Interventions
for smoking cessation in patients admitted with acute
coronary syndrome: A review. Postgraduate Medical
Journal, 94(1108), 116–120.
https://doi.org/10.1136/postgradmedj-2017-135040.

Systematic review

Assessing the effectiveness of
pharmacological, behavioral, or a
combination of the two smoking
interventions among patients
admitted with the acute coronary
syndrome.

A combination of the behavioral
and pharmacological smoking
interventions was more effective
than individual programs.

de Hoog, N., Bolman, C., Berndt, N., Kers, E., Mudde,
A., de Vries, H., & Lechner, L. (2016). Smoking
cessation in cardiac patients: the influence of action
plans, coping plans, and self-efficacy on quitting
smoking. Health Education Research, 31(3), 350–362.

Longitudinal study

The study's objective was to review
the predictors of the behavioral
relationship in smoking cessation in
cardiac patients.

There was a positive correlation
between the predictors of
behavioral change. 31% of the
respondents had not smoked in 6
months' time, and 43% had not
smoked in the previous seven
days.

https://doi.org/10.1093/her/cyv100
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Purpose of the study

Results

Goettler, D., Wagner, M., Faller, H., Kotseva, K.,
Wood, D., Leyh, R., Ertl, G., Karmann, W.,
Heuschmann, P. U., Störk, S., & German
EUROASPIRE IV Collaborators (2020). Factors
associated with smoking cessation in patients with
coronary heart disease: A cohort analysis of the German
subset of EuroAspire IV survey. BMC Cardiovascular
Disorders, 20(1), 152-165.
https://doi.org/10.1186/s12872-020-01429-w

Cross-sectional study

The aim of the study was to assess
smoking cessation patterns and
determine factors associated with
smoking cessation in patients with
established CHD.

Approximately 63% of the
patients had quit smoking after
attending the cardiac
rehabilitation program, and
quitters (37.5%) instead of current
smokers (20.5%) attended most of
the classes.

Gupta, R., Gupta, S., Sharma, S., Sinha, D. N., &
Mehrotra, R. (2019). Risk of coronary heart disease
among smokeless tobacco users: Results of Systematic
review and meta-analysis of global data. Nicotine &
Tobacco Research, 21(1), 25–31.
https://doi.org/10.1093/ntr/nty002

Systematic review

Examining the risk of CHD among
adults ever-users of smokeless
tobacco (SLT).

A summary of the CHD risks in
SLT users was not statistically
significant positive (1.05, 95% CI
[0.96- 1.15]).

Hyndman, K., Thomas, R. E., Schira, H. R., Bradley, J.,
Chachula, K., Patterson, S. K., & Compton, S. M.
(2019). The effectiveness of tobacco dependence
education in health professional students' practice: A
systematic review and meta-analysis of randomized
controlled trials. International Journal of
Environmental Research and Public Health, 16(21),
4158. https://doi.org/10.3390/ijerph16214158.

Systematic review

The aim of the study was to
conduct a systematic review to
evaluate the effectiveness of
tobacco dependence education
versus usual or no tobacco
dependence education on entrylevel health professional student
practice and client smoking
cessation.

Tobacco dependence counselling
resulted in 78 out of a 1000
quitting smoking in six months
(OR 2.02, 95% CI [1.49- 2.74], r2
= 0, p = 0.76; p < 0.000001).

Lee, H., & Son, Y. J. (2019). Influence of smoking
status on risk of incident heart failure: A systematic
review and meta-analysis of prospective cohort studies.
International Journal of Environmental Research and
Public Health, 16(15), 2697-2707.
https://doi.org/10.3390/ijerph16152697

Cohort study

Identifying the relationship of
smoking status with incident risk of
heart failure.

Current smokers had a high
hazard ratio (H.R.) of heart failure
(H.R. = 1.209, 95% CI [1.4701.761]). Former smokers had a
higher risk of heart failure than
those who never smoked (H.R. =
1.209. 95% CI [ 1.084- 1.348]).
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Mullen, K. A., Manuel, D. G., Hawken, S. J., Pipe, A.
L., Coyle, D., Hobler, L. A., Younger, J., Wells, G. A.,
& Reid, R. D. (2017). Effectiveness of a hospitalinitiated smoking cessation program: 2-year health and
healthcare outcomes. Tobacco Control, 26(3), 293–299.
https://doi.org/10.1136/tobaccocontrol-2015-052728
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Purpose of the study

Results

The aim of the study was to
ascertain the implementation of a
hospital-initiated smoking cessation
intervention would decrease deaths
and downstream healthcare usage.

The intervention group had the
lowest smoking-related, all-cause
readmissions and emergency
department visit rates at all the
points. The highest absolute risk
reduction (ARR) was observed for
all-cause readmission at 30 days
(ARR, 6.1%, p < 0.001).

Patterson, F., Zaslav, D. S., Kolman-Taddeo, D.,
Cuesta, H., Morrison, M., Leone, F. T., & Satti, A.
(2017). Smoking cessation in pulmonary care subjects:
A mixed-methods analysis of treatment-seeking
participation and preferences. Respiratory Care, 62(2),
179–192. https://doi.org/10.4187/respcare.04958

A mixed-method
approach

The objective of the study was to
identify barriers and predictors to
smoking cessation in African
American population.

58% of the pulmonary
participants enrolled in smoking
cessation classes, and 16%
attended all the classes.

Prochaska, J. J., & Benowitz, N. L. (2016). Smoking
cessation and the cardiovascular patient. Current
Opinion in Cardiology, 30(5), 506–511.
https://doi.org/10.1097/HCO.0000000000000204

Systematic review

Assessing smoking cessation
interventions among cardiovascular
disease patients and the health
outcome.

A combination of tobacco
reduction use interventions is
effective and includes fewer risks.

Rice, V. H., Heath, L., Livingstone-Banks, J., &
Hartmann-Boyce, J. (2017). Nursing interventions for
smoking cessation. The Cochrane Database of
Systematic Reviews, 12(12), CD001188.
https://doi.org/10.1002/14651858.CD001188.pub5

Systematic review

To determine the effectiveness of
nursing delivered smoking
cessation interventions in adults.

The nursing-based intervention
increased the probability of
quitting smoking (relative risk
(RR 1.29, 95% CI [1.21- 1.38]),
and statistical heterogeneity was
moderate (I2 = 50%).
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Snaterse, M., Deckers, J. W., Lenzen, M. J., Jorstad, H.
T., De Bacquer, D., Peters, R., Jennings, C., Kotseva,
K., Scholte Op Reimer, W., & EUROASPIRE
Investigators (2018). Smoking cessation in European
patients with coronary heart disease. Results from the
EUROASPIRE IV survey: A registry from the
European Society of Cardiology. International Journal
of Cardiology, 258, 1–6.
https://doi.org/10.1016/j.ijcard.2018.01.064

Suissa, K., Larivière, J., Eisenberg, M. J., Eberg, M.,
Gore, G. C., Grad, R., Joseph, L., Reynier, P. M., &
Filion, K. B. (2017). Efficacy and safety of smoking
cessation interventions in patients with cardiovascular
disease: A network meta-analysis of randomized
controlled trials. Circulation. Cardiovascular Quality
and Outcomes, 10(1), e002458.
https://doi.org/10.1161/CIRCOUTCOMES.115.002458

Randomized control
study.
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Purpose of the study

Results

To examine smoking cessation rates
in CHD patients and the traits of
successful smoking quitters.

31% of the smokers enrolled for
the intervention recruitment event;
15% in Finland, and 57% in
Cyprus. 56% of the successful
quitters were advised on smoking
cessation and attended the cardiac
rehabilitation program.

The article's aim was to appraise
the safety and efficacy of
pharmacological and behavioral
smoking cessation interventions in
CVD patients.

In pharmacological interventions,
varenicline (RR, 2.64, 95% CI
[1.34 – 5.21]) and bupropion (RR:
1.42, 95% CI [1.01- 2.01]) were
more effective, telephone therapy
(RR: 1.47, 95% CI [1.15- 1.88])
and individual counselling (RR:
1.64, 95% CI [1.17- 2.28]) were
more effective than usual care.
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SECTION FIVE: DISCUSSION
The smoking cessation interventions included pharmacological, behavioral, telephone,
and nursing-based interventions. The interventions effectively aided the CVD and CHD patients
with quitting smoking and abstaining from tobacco dependency. In addition, there were shortterm and long-term follow-up sessions that assessed the abstinence process of smoking cessation
among the participants. Behavioral interventions were effective and had a statistically significant
effect on smoking cessation; RR: 1.23, 95% CI (1.12 to 1.34), RR: 1.47, 95% CI (1.15 to 1.88),
and RR 1.66, 95% CI (1.42 to 1.9). Pharmacological interventions were also efficacious in
abstaining from tobacco use as the studies reported statistical significance, particularly
varenicline; RR: 2.64 95% CI (1.34 to 5.21) and Bupropion; RR: 1.42, 95% CI (1.01 to 2.01).
Individual counseling and telephone therapy interventions were also effective in smoking
cessation among the participants; RR: 1.64, 95% CI (1.17 to 2.28) and RR: 1.47 95% CI (1.15 to
1.88), respectively.
A combination of pharmacological and behavioral therapy was most effective and safe,
having the highest likelihood of abstinence compared to other therapies and interventions
implemented; RR 1.83, 95% CI (1.68 to 1.98). Initiating smoking cessation aided in reducing
hospital readmission, hence saving on cost and health risks. Based on the results of the articles
reviewed, the smoking cessation programs and interventions were effective in aiding the patients
with CVD and CHD in quitting tobacco use. Additionally, there was a reduction in hazards and
relative risks associated with nicotine dependency. Follow-up sessions, short- and long-term,
were essential in assessing the progress of the participants and the efficacy of using the
intervention initiated.
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Implications for Practice
The findings indicated significant success with smoking cessation among patients
diagnosed with CVD and CHD diseases. The practical implications in the study include
incorporating smoking cessation interventions in clinical and rehabilitation centers and
identifying the predictors of successful abstinence traits. Pharmacological, behavioral, telephone
contacts, and individual counseling interventions should be implemented to reduce the number of
CVD and CHD patients who smoke. Smoking cessation has health benefits, such as enhancing
the quality of life and decreasing mortality rates, and adverse health risks, such as respiratory
diseases and cancer. Smoking cessation also minimizes financial burden and the occurrence of
heart attacks (CDC, 2020).
The limitations of the study were associated with the type of method applied. The
demerits of an integrative review included the combination of different methodologies used in
the articles, which led to a lack of rigor, bias, and inaccuracy while reducing the comprehensive
summary in analyzing, synthesizing, and drawing of inferences (Temple Universities Libraries,
2021). Bias was reduced by engaging reviewers during the screening process to obtain diverse
opinions from professionals on the articles selected.
Sustainability
Continual follow-up at healthcare institutions should occur to evaluate both the
interventions implemented and patients in ceasing tobacco use to sustain the project findings.
Educational training regarding the importance and selection of the appropriate smoking cessation
interventions should be implemented to encourage programs aimed at aiding patients to abstain
from tobacco use. The interventions could be initiated in a healthcare facility or a rehabilitation
center.
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Dissemination Plan
The project findings will be distributed in institutions, such as the Veteran Administration
Center for Information Dissemination and Educational Resources, to help healthcare
practitioners select cessation interventions for CVD and CHD patients. The findings will also be
disseminated in the community through health promotion events and a cardiovascular nursing
symposium focusing on the advantages of quitting tobacco use. A copy of the project will be
stored in the Liberty University library so that nursing students may access the articles.
Summary
This study was an integrative review assessing the effectiveness of smoking cessation
programs in heart disease patients. Tobacco use leads to health risks, such as cardiovascular,
respiratory, cancer-related diseases, and mortality. Smoking cessation programs have been
developed and implemented to aid in abstinence from tobacco use to enhance patients' health. An
integrative review study was performed to appraise the effectiveness of smoking cessation in
heart disease patients. Fifteen articles were screened; 14 were eligible and selected for review.
The type of interventions implemented included behavioral, pharmacological, telephone,
individual counseling, and nurse-based programs. All the interventions were effective in helping
the participants abstain from smoking and tobacco dependency. A PRISMA flowchart was used
to display the process of selecting, sorting, screening, and inclusion of the articles. The
implication of the project entails adopting the intervention in healthcare and rehabilitation
centers to reduce the number of CVD and CHD patient smokers, while sustainability plans
include frequent follow-ups and educational training about the importance of quitting tobacco
use. The project findings will be disseminated in the Liberty University library, in communities
through health promotion events, and at conferences to reach a wider audience.
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Appendix A: Evidence Table
Table A1
Evidence Table
Article

Author
(year)

Article 1

Barth et al.
(2016).

Article 2

Blane et al.
(2017).

Article 3

Chehab and
Dakik (2018).

Study purpose/
Objective(s)
To evaluate the
efficacy of
psychosocial
interventions for
smoking cessation
among coronary
heart disease
patients in short‐
term and long‐term
(over 12 months)
To determine the
link between
different patterns of
comorbidity and
smoking rates and
smoking cessation
interventions in
primary care for
patients with CHD.

To review the
findings on
interventions applied
for smoking
cessation after acute
coronary syndrome
(ACS).

Design, sampling
method, &
subjects
A systematic
review
N = 40 RCTs

An observational
cross-sectional
study
N = 81 456 adults
with CHD in
primary care

LOE*

Intervention &
outcome

Study strengths &
limitations

Level I

Smoking cessation
interventions
comprised of
behavioral
therapeutic, use of
self‐help material and
approaches, telephone
support.

Psychosocial
smoking
cessation
interventions
were more
effective in
enhancing
abstinence up to
one year.

The review focused on
RCTs in patients
diagnosed with CHDs.
The studies that focused
on the term effects of
the intervention were
limited.

Level IV

Approximately 15 395
(91.9%) of the
smokers received
smoking cessation
advice in 15 months.

Adults with
CHD require
cessation
support.
Smoking
cessation is
limited among
patients with
mental illness
and CHD

A large dataset (>
80,000 patients with
CHD) was used. Lacks
the specific smoking
cessation advice
provided to patients.
A cross-sectional study
limited the ability to
ascertain the causality of
the observed
associations.
The strength is
associated with the use
of systematic reviews
and meta-analyses.
It is limited to only five
studies.

Also, 14.5% received
a prescription.

Systematic
reviews
N = 5 studies

Results

Level I

Use pharmacological
interventions for
smoking cessation
(nicotine replacement
therapy [NRT],
Varenicline, and
bupropion).
Behavioral
interventions were

NRT use in
ACS had
inconclusive
results. Also,
three trials of
bupropion failed
to indicate
improvement in
smoking
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Author
(year)

Study purpose/
Objective(s)

Design, sampling
method, &
subjects
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LOE*

Intervention &
outcome
also applied. A
combination of
behavioral and
pharmacological
interventions for
smoking cessation
was considered
effective.

Article 4

de Hoog et al.
(2016).

To examine the
influence of action
plans, coping plans,
and self-efficacy on
quitting and
smoking cessation in
cardiac patients.

A longitudinal
study.
N = 245 cardiac
patients

Level IV

The use of coping
plans, action plans
After six months (N =
184), abstained from
smoking.

Article 5

Goettler et al.
(2020).

To evaluate smoking
cessation patterns
and establish factors
linked with smoking
cessation in patients

Cohort studies
N = 469
participants
diagnosed with
CHD.

Level IV

Use of telephone
interviews and cardiac
rehabilitation.
About 65 patients
(62.5%) quit smoking

Results
cessation.
However, one
trial of
Varenicline
provided
positive results
in achieving
smoking
abstinence. The
behavioral
interventions
found that
telephone
counseling
promoted
smoking
cessation. The
combination of
behavioral and
pharmacological
interventions
was more
effective.
Findings
indicated that
184 continued
with abstinence
from smoking.
Intention to quit
smoking six
months later
Cardiac
rehabilitation
was linked with
smoking
cessation (OR

Study strengths &
limitations

The strength is that the
study shows factors
influencing the intention
to stop smoking. The
limitation is that the
questionnaire was
administrated while
patients were at the
hospital.
A large sample of
participants was used.
The study was limited to
a small sample for a
cohort study.
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(year)

Study purpose/
Objective(s)

Design, sampling
method, &
subjects
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LOE*

with established
CVD.

Article 8

Lee & Son
(2019).

To identify the link
between smoking
status with incident
risk of heart failure

A systematic
review and metaanalysis of
prospective cohort
studies
N = 7 studies
(42,759
participants)

Level III

Article 9

Mullen et al.
(2017).

To establish if
implementing a
hospital-initiated
smoking cessation
intervention reduces
mortality.

A cross-sectional
study.
N = 1367 smokers
(726 used for
cessation
intervention, 641
were usual care
controls.

Level IV

Intervention &
outcome

Results

during a telephone
interview.
Cardiac rehabilitation
was linked with
smoking cessation
95% CI.
Smoking cessation
among patients with
H.F. Former smokers
have a higher risk of
H.F. incidence in
comparison to
nonsmokers (H.R. =
1.209, 95% CI).

5.19; 95%CI
1.87 to 14.46; p
= 0.002

A -2-effectiveness
study was conducted,
using an 'Ottawa
Model' for Smoking
Cessation
intervention.
The intervention
group has lower rates
of all0cause
readmissions, allcause emergency
department (ED)
visits, and smokingrelated readmissions.

Smoking
cessation did
not result in a
reduction in
mortality within
30 days.
However,
significant
decreases were
reported after
one year (11.4%
vs. 5.4%).

Health
professionals
must support
cessation among
current smokers
because of the
high risk of H.F.

Study strengths &
limitations

The main strength is that
large prospective cohort
studies were analyzed,
identifying the causal
link between H.F.
incidence risks and
smoking status. The
article was limited to the
meta-analysis of
prospective cohort
studies with no RCTs
A large sample of 1367
was utilized in the
study. The study was
limited to only
healthcare usage in
Ontario, Canada. Also,
no information was
provided about the
specific use of cessation
medication.
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Article
Article
10

Author
(year)
Patterson et al.
(2017).

Study purpose/
Objective(s)
To identify the
predictors and
barriers to smoking
cessation in African
American smokers
with

Design, sampling
method, &
subjects
A retrospective
chart review and
qualitative studies.

50

LOE*
Level III

N = 253
participants

Article
11

Prochaska &
Benowitz (2016).

To review research
on the treatment of
cigarette smoking,
heart patients, and
CVD outcomes.

A literature review
of evidence. The
sample of studies
reviewed was
omitted.

Level I

Article
12

Rice et al.
(2017).

To establish the
effectiveness of
nursing‐delivered
smoking cessation
interventions among
adults.

A systematic
review and metaanalysis
N = 15 studies
reviewed

Level I

Intervention &
outcome
A smoking cessation
program for the
population.
Smoking cessation
program attendance
among African
American smokers
was poor.
Pulmonary care
patients wanted to
quit smoking
Cessation
pharmacotherapy on
CVD and Varenicline
was effective.
Telehealth and
incentives were used
to promote smoking
cessation.
A meta-analysis of
telehealth smoking
cessation
interventions was
effective.

Combined efforts of
healthcare providers
in smoking cessation.
The smoking
cessation
interventions with
multiple clinician
types were more
effective (95% CI
1.9).

Results

Study strengths &
limitations

Smoking
cessation
program is
effective in
increasing
knowledge on
quitting tobacco
use

A mixed approach was
used to address smoking
cessation.
A relatively low
attendance rate
exacerbated
participation bias.

A 2011 metaanalysis of nine
trials showed
that incentives
increased
smoking
cessation and
abstinence.
Toll-free
telephone
questlines allow
access to
cessation
counseling and
reduce tobacco
use.
Smoking
cessation lead
by nurses
resulted in a
modest
improvement in
tobacco use
abstinence
Healthcare
providers are

The study entails the use
of systematic reviews
and meta-analyses. The
study was limited to
studies conducted
between 2013 and 2015

The quality of evidence
used was moderate.
Possible methodological
limitations of both the
systematic review and
the RCTs.
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Article

Author
(year)

Article
13

Semwal et al.
(2019).

Article
14

Snaterse et al.
(2018).

Article
15

Suissa et al.
(2017).

Study purpose/
Objective(s)

To assess digital
education
effectiveness
compared with
different controls in
improving
knowledge, skills,
attitudes, and
satisfaction of
learners on smoking
cessation therapy
delivery.
To investigate
smoking cessation
rates in CHD
patients in Europe
and compared to
EUROASPIRE
survey

To evaluate the
safety and efficacy
of behavioral and
pharmacological
smoking cessation
interventions among
patients with CVD

Design, sampling
method, &
subjects

51

LOE*

Intervention &
outcome

Results
effective in
promoting
smoking
cessation, 95%
CI 1.3 to 2.1)
Digital
education is
limited in its
abilities but can
help improve
professionals'
knowledge for
the delivery of
smoking
cessation
therapy.

Study strengths &
limitations

A systematic
review and metaanalysis of RCTs
N = 11 (number of
participants, n =
2684

Level I

Digital education to
deliver smoking
cessation therapy. The
educational approach
showed more
significant
improvements in
knowledge (95% CI).

The authors used
systematic review and
meta-analysis of RCTs.
The study was limited to
the use of digital
education on smoking
cessation.

EUROASPIRE IV
based on a crosssectional study N=
7998 patients from
the
EUROASPIRE-IV
survey with
myocardial
infarction
coronary
revascularization,
and unstable
angina.
Systematic
reviews for metaanalysis of RCTs.
Seven
pharmacotherapy
RCTs (n = 2809)
and 17 behavioral

Level III

Smoking cessation
intervention. About
31% of the
participants were
smokers and the rate
of successful quitters
was relatedly low.
Smoking cessation
increased with
education (CI 95%)
and age.

Successful
quitters reported
being advised
(56% vs. 47%,
pb.001) and
they attended a
cardiac
rehabilitation
program ((81%
vs. 75%, pb.01).

A large sample of CHD
patients was derived
from 24 European
nations.
Data was limited to
EUROASPIRE IV
survey, and the findings
may not be generalized
to individual countries.

Level 1

Behavioral and
pharmacological
smoking cessation
interventions.
The pharmacotherapy
reviews have greater

Individual and
telephone
counseling was
efficacious
when used for
smoking

Use of systematic
reviews from
MEDLINE, EMBASE,
Psyc INFO, and
Cochrane databases.
The limitation of the
study was restricted to
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Article

Author
(year)

Study purpose/
Objective(s)
patients using a
meta-analysis of
RCTs.

Design, sampling
method, &
subjects
intervention RCTs
(n = 4666)
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LOE*

Intervention &
outcome

Results

smoking abstinence
with active treatment.

cessation among
CVD patients.

Study strengths &
limitations
the aggregate data
provided in the
published articles.
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Appendix B: Integrative Review Conceptual Framework
Figure B1
Integrative Review Conceptual Framework

Note. Adapted from Covidence [Computer software], by J. M. Hansen, 2021
(https://www.covidence.org/).

53

SMOKING CESSATION IN HEART DISEASE PATIENTS

54

Appendix C: Institutional Review Board
LIBERTY UNIVERSITY INSTITUTIONAL REVIEW BOARD
July 6, 2021

Re: IRB Application - IRB-FY20-21-1 Effectiveness of the Smoking Cessation in Heart Disease Patients:
An Integrative Review

The Liberty University Institutional Review Board (IRB) has reviewed your application in accordance
with the Office for Human Research Protections (OHRP) and Food and Drug Administration (FDA)
regulations and finds your study does not classify as human subjects' research. This means you may begin
your project with the data safeguarding methods mentioned in your IRB application.

Decision: No Human Subjects Research

Explanation: Your study is not considered human subjects research for the following reasons:

-It will not involve the collection of identifiable, private information.
-" Scholarly and journalistic activities (e.g., oral history, journalism, biography, literary criticism, legal
research, and historical scholarship), including the collection and use of information, which focus directly
on the specific individuals about whom the information is collected," are not considered research according
to 45 CFR 46.102(I)(1).

Please note that this. Decision only applies to your current application, and any modifications to your
protocol must be reported to the Liberty University IRB for verification of continued non-human subjects
research status. You may report these changes by completing a modification submission through your
Cayuse IRB account.

Also, although you are welcome to use our recruitment and consent templates, you are not required to do
so. If you choose to use our documents, please replace the word research with the word project
throughout both documents.

If you have any questions about this determination or need assistance in determining whether possible
modifications to your protocol would change your application's status, please email us at irb@liberty.edu.
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